Published in Pediatr Blood Cancer on April 01, 2010
Deregulation of ion channel and transporter encoding genes in pediatric gliomas. Front Oncol (2012) 0.76
An infant with hyperalertness, hyperkinesis, and failure to thrive: a rare diencephalic syndrome due to hypothalamic anaplastic astrocytoma. BMC Cancer (2015) 0.75
Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature. Contemp Oncol (Pozn) (2012) 0.75
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA. J Transplant (2011) 0.75
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol (2005) 2.24
Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol (2013) 2.05
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. J Neurosurg (2006) 1.93
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol (2008) 1.92
Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med (2002) 1.74
Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatr Dev Pathol (2007) 1.70
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol (2003) 1.67
The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol (2003) 1.66
O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol (2006) 1.66
BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res (2011) 1.61
Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr (2009) 1.58
Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors. Pediatr Blood Cancer (2010) 1.57
Delayed surgical resection of central nervous system germ cell tumors. Neurosurgery (2002) 1.57
Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer (2008) 1.56
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer (2008) 1.55
Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer (2004) 1.49
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol (2010) 1.48
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol (2004) 1.28
Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol (2010) 1.23
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion. Int J Cancer (2004) 1.13
Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery (2002) 1.12
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol (2012) 1.09
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol (2002) 1.08
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer (2010) 1.05
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neuro Oncol (2010) 1.04
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol. J Clin Oncol (2004) 1.04
Identification and characterization of the novel centrosome-associated protein CCCAP. Gene (2003) 1.03
Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol (2003) 1.01
Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol (2004) 1.00
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol (2003) 0.99
Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Pediatr Blood Cancer (2008) 0.99
Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr Blood Cancer (2011) 0.98
High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer (2004) 0.97
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group. Pediatr Blood Cancer (2012) 0.97
Choroid plexus carcinoma in children: the Head Start experience. Pediatr Blood Cancer (2015) 0.96
Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg (2003) 0.96
Aggressive variant of a papillary glioneuronal tumor. Report of 2 cases. J Neurosurg Pediatr (2009) 0.94
Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer (2010) 0.94
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Pediatr Blood Cancer (2008) 0.93
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer (2013) 0.93
Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol (2010) 0.93
Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol (2007) 0.92
Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience. J Neurooncol (2007) 0.91
Survey of quality, readability, and social reach of websites on osteosarcoma in adolescents. Patient Educ Couns (2012) 0.90
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J Neurooncol (2003) 0.90
Surgical management of primary central nervous system germ cell tumors: proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. J Neurosurg Pediatr (2010) 0.88
Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol (2003) 0.88
Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol (2009) 0.88
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group. Pediatr Blood Cancer (2010) 0.88
Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol (2002) 0.88
Treatment of refractory neurosarcoidosis with cladribine. N Engl J Med (2004) 0.87
A phase II trial of carboplatin for intraocular retinoblastoma. Pediatr Blood Cancer (2007) 0.87
Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging (2006) 0.87
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol (2006) 0.87
Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol (2011) 0.85
High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol (2002) 0.84
New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res (2013) 0.84
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group. Br J Haematol (2013) 0.83
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatr Blood Cancer (2008) 0.83
Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature. J Pediatr Hematol Oncol (2009) 0.83
Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation. Int J Radiat Oncol Biol Phys (2013) 0.82
Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine. J Pediatr Hematol Oncol (2003) 0.82
Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. J Pediatr Hematol Oncol (2003) 0.81
Regression of primary central nervous system germinoma after dexamethasone administration: a case report. Pediatr Hematol Oncol (2010) 0.81
Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivors. J Neurooncol (2010) 0.81
State of the art chemotherapeutic management of pediatric brain tumors. Expert Rev Neurother (2006) 0.81
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer (2011) 0.81
Magnetic resonance imaging features of meningiomas in children and young adults: a retrospective analysis. J Neuroradiol (2011) 0.80
Recurrent central nervous system medulloepithelioma: response and outcome following marrow-ablative chemotherapy with stem cell rescue. J Pediatr Hematol Oncol (2005) 0.80
Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol (2014) 0.80
Metabolism of orthotopic mouse brain tumor models. Mol Imaging (2009) 0.79
Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group report. J Neurooncol (2003) 0.79
Evaluation of quality improvement initiative in pediatric oncology: implementation of aggressive hydration protocol. J Nurs Care Qual (2009) 0.77
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group. Pediatr Blood Cancer (2012) 0.77
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group. Pediatr Blood Cancer (2013) 0.77
Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol (2013) 0.77
Pineal region tumors in children. Curr Opin Neurol (2010) 0.77
The role of chemotherapy in pediatric clival chordomas. J Neurooncol (2010) 0.76
Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer (2013) 0.76
Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. J Oncol Pharm Pract (2013) 0.76
Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma. J Pediatr Hematol Oncol (2010) 0.76
Recurrent pure CNS germinoma with markedly elevated serum and cerebrospinal fluid human chorionic gonadotropin-beta (HCGβ). Pediatr Blood Cancer (2010) 0.76
The management of children and adolescents with medulloblastoma in low and middle income countries. Pediatr Blood Cancer (2014) 0.75
Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945. J Neurooncol (2014) 0.75
Management of children with brain tumors in Paraguay. Neuro Oncol (2012) 0.75
Structural brain alterations in children an average of 5 years after surgery and chemotherapy for brain tumors. J Neurooncol (2014) 0.75
Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial Efficiency. J Pediatr Hematol Oncol (2016) 0.75
Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma. Pediatr Blood Cancer (2013) 0.75
A retrospective analysis of recurrent intracranial ependymoma. Pediatr Blood Cancer (2014) 0.75
Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors. Pediatr Blood Cancer (2013) 0.75
Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors. CNS Oncol (2013) 0.75
Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation. J Neurooncol (2011) 0.75